Compare AdaptHealth Corp (AHCO) vs Logitech International SA (LOGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AdaptHealth Corp vs Logitech International SA — how do they compare? AdaptHealth Corp trades at $5.7 (market cap $753.09M), while Logitech International SA trades at $102.13 (market cap $14.96B). The key difference: Logitech International SA is far larger — about 19.9× AdaptHealth Corp's market cap, and Logitech International SA pays a 1.64% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | LOGI | |
|---|---|---|
Market Cap | $753.09M | $14.96B |
Sector | Health | Technology |
52-Week High | $13.38 | $126.69 |
52-Week Low | $5.22 | $85.84 |
Enterprise Value | $2.77B | $13.30B |
Dividend Yield | — | 1.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $5.63, up 7.85% today but remains under significant pressure after recent earnings disappointments. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal negative profitability with a -6.82% net margin and three consecutive quarterly earnings misses. The company is restructuring by selling its diabetes unit to focus on sleep and respiratory care, but faces multiple securities fraud investigations following guidance revisions.
Despite 75% analyst buy ratings and an $11 consensus price target suggesting 95% upside, substantial risks exist including ongoing legal probes, execution challenges with new fixed-price contracts, and negative cash flow trends. The stock presents high-risk speculation amid operational restructuring and legal uncertainties.
Logitech (LOGI) trades at $101.92, down 2.81% amid technical bearish signals and supply chain concerns. The stock shows strong fundamentals with three consecutive quarterly earnings beats, robust 35.29% ROE, and 16.28% net margins. Recent Q1 2027 results exceeded expectations with $1.85 EPS versus $1.26 expected, though a semiconductor supplier shutdown creates near-term uncertainty.
Outlook remains mixed with 26% upside to consensus $109.75 target but tempered by supply risks. Investment case hinges on Logitech's premium product demand and margin expansion potential, balanced against Q3 2027 supply constraints and divided analyst sentiment (26% Buy, 47% Hold, 26% Sell).
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →
